0001209191-18-045833.txt : 20180808 0001209191-18-045833.hdr.sgml : 20180808 20180808162843 ACCESSION NUMBER: 0001209191-18-045833 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180806 FILED AS OF DATE: 20180808 DATE AS OF CHANGE: 20180808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAHAM GINGER L CENTRAL INDEX KEY: 0001192601 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 181001766 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS, INC. STREET 2: 885 ARAPAHOE AVENUE CITY: BOULDER STATE: CO ZIP: 80302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-06 0 0001131324 GENOMIC HEALTH INC GHDX 0001192601 GRAHAM GINGER L 1108 NORTH LEMAY AVENUE FORT COLLINS CO 80524 1 0 0 0 Common Stock 2018-08-06 4 M 0 16500 17.33 A 26756 I Held by the GInger L. Graham Revocable Trust Director Stock Option (right to buy) 17.33 2018-08-06 4 M 0 16500 0.00 D 2018-12-04 Common Stock 16500 0 D The option became exercisable as to 25% of the shares on December 4, 2009, and became exercisable as to 1/48th of the shares each full month thereafter. /s/ Jason W. Radford, Attorney-in-fact 2018-08-08